Effect of examining lymph nodes count on mortality risk in resected T1 non-small-cell lung cancer.

ABSTRACT:

Objectives

This study aims to estimate the effect of the examined lymph node count (ELNC) on the cancer-related mortality risk and non-cancer-related mortality risk in patients with resected T1 non-small-cell lung cancer (NSCLC).

Methods

Patients diagnosed as primary T1 NSCLC between 2000 and 2017 were extracted from the Surveillance, Epidemiology and End Results database. Patients were divided into 2 groups according to the ELNC cutoff value, which was calculated based on overall survival outcomes. Propensity score matching was used to equalize the differences in baseline characteristics between groups.

Results

A total of 38 242 resected T1 NSCLC patients were extracted from the database with the ELNC cutoff value of 8. After propensity score matching, 27 676 patient

SUBMITTER: Zeng J 

PROVIDER: S-EPMC10873909 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature